Ferrous Acetyl-Aspartate Casein Formulation Evaluation Over Ferrous Sulfate in Iron Deficiency Anemia
Status:
Completed
Trial end date:
2021-01-08
Target enrollment:
Participant gender:
Summary
The scope of this study is to compare the efficacy of the new oral formulation of Fe-ASP to
oral ferrous sulfate in patients with iron deficiency anemia (IDA) for the restoration of
decreased circulating Hb. The improvement of symptoms of anemia, the restoration of
biomarkers of iron deficiency into the normal range and the incidence of GI tract side
effects are the study secondary endpoints.